Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes (CTL) for the treatment of patients with EBV-positive relapsed nasopharingeal carcinoma

被引：0
|
作者：
Comoli, P
Pedrazzoli, P
Nocera, A
Labirio, M
Del Galdo, F
Basso, S
Schiavo, R
Tagliamacco, A
Carminati, O
De Palma, R
Siena, S
Locatelli, F
Maccario, R
机构：
来源：
BONE MARROW TRANSPLANTATION | 2002年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P709
引用
收藏
页码：S191 / S191
页数：1
相关论文
共 50 条
  • [31] Epstein - Barr virus specific cytotoxic T lymphocytes for the treatment of severe epstein-barr virus mucocutaneous ulcer
    Khazal, Sajad
    Ragoonanan, Dristhi
    Hosing, Chitra
    Williams, LaTarsha
    Medeiros, L. Jeffrey
    Mahadeo, Kris M.
    Thompson, Philip A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (02) : E33 - E36
  • [32] LOCAL SUPPRESSION OF EPSTEIN-BARR-VIRUS (EBV)-SPECIFIC CYTOTOXICITY IN BIOPSIES OF EBV-POSITIVE HODGKINS-DISEASE
    FRISAN, T
    SJOBERG, J
    DOLCETTI, R
    BOIOCCHI, M
    DE RE, V
    CARBONE, A
    BRAUTBAR, C
    BATTAT, S
    BIBERFELD, P
    ECKMAN, M
    OST, O
    CHRISTENSSON, B
    SUNDSTROM, C
    BJORKHOLM, M
    PISA, P
    MASUCCI, MG
    BLOOD, 1995, 86 (04) : 1493 - 1501
  • [33] Synchronous discordant Epstein-Barr virus (EBV)-positive nodal T/NK-cell lymphoma and EBV-positive diffuse large B cell lymphoma in a patient with a history of EBV-positive Burkitt lymphoma
    Opsahl, Madeleine P.
    Hammer, Richard D.
    Laziuk, Katsiaryna
    JOURNAL OF HEMATOPATHOLOGY, 2018, 11 (04) : 119 - 125
  • [34] Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas
    Yilmaz, Elif
    Lakhotia, Rahul
    Pittaluga, Stefania
    Muppidi, Jagan R.
    Phelan, James D.
    Evans, Sarah
    Pradhan, Amynah
    Hillsman, Amy
    Steinberg, Seth M.
    Jaffe, Elaine S.
    Wilson, Wyndham H.
    Roschewski, Mark
    Melani, Christopher
    BLOOD, 2021, 138
  • [35] Cell therapy with EBV LMP2-specific cytotoxic T-lymphocytes for patients with nasopharingeal carcinoma
    Comoli, P.
    Basso, S.
    Secondino, S.
    Gurrado, A.
    Morbini, P.
    Benazzo, M.
    Quartuccio, G.
    Guido, I.
    Pellerano, A.
    Paglino, C.
    Zecca, M.
    Pedrazzoli, P.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S310 - S311
  • [36] Epstein-Barr virus (EBV) infection in salivary gland tumors: Lytic EBV infection in nonmalignant epithelial cells surrounded by EBV-Positive T-lymphoma cells
    Wei, SM
    Mizugaki, Y
    Shinozaki, F
    Takada, K
    VIROLOGY, 1997, 227 (02) : 484 - 487
  • [37] Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells
    Ohashi, Akiko
    Kato, Seiichi
    Okamoto, Akinao
    Inaguma, Yoko
    Satou, Akira
    Tsuzuki, Toyonori
    Emi, Nobuhiko
    Okamoto, Masataka
    Nakamura, Shigeo
    HISTOPATHOLOGY, 2017, 71 (01) : 89 - 97
  • [38] EPSTEIN-BARR-VIRUS (EBV) GENE-EXPRESSION IN EBV-POSITIVE PERIPHERAL T-CELL LYMPHOMAS
    CHEN, CL
    SADLER, RH
    WALLING, DM
    SU, IJ
    HSIEH, HC
    RAABTRAUB, N
    JOURNAL OF VIROLOGY, 1993, 67 (10) : 6303 - 6308
  • [39] Chidamide Induces Epstein-Barr Virus (EBV) Lytic Infection and Acts Synergistically with Tenofovir to Eliminate EBV-Positive Burkitt Lymphoma
    Xu, Linyan
    Zhang, Meng
    Tu, Dongyun
    Lu, Ziyi
    Lu, Tianyi
    Ma, Dongshen
    Zhou, Yi
    Zhang, Shuo
    Ma, Yuhan
    Yan, Dongmei
    Wang, Xiangmin
    Sang, Wei
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 387 (03): : 288 - 298
  • [40] Infusion of autologous Epstein-Barr Virus (EBV)-specific cytotoxic T cells can treat chronic active EBV infection.
    Savoldo, B
    Huls, HM
    Liu, ZS
    Volk, HD
    Reinke, P
    Sabat, R
    Babel, N
    Jones, JF
    Gee, AP
    Brenner, MK
    Heslop, HE
    Rooney, CM
    BLOOD, 2001, 98 (11) : 502A - 502A
12345